ScholarLens Back to search
2012•Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиологияRequires access

Методология анализа «Затраты -эффективность» при проведении фармакоэкономических исследований

Р. И. Ягудина, A.Yu. Kulikov, I. Metelkin

Open publisher page 1 citations

Abstract

Cost-effectiveness analysis (CEA) is a frequently used method of pharmacoeconomic analysis. Its major parts are cost analysis, effectiveness analysis and results estimation. Undertaking of each part effects the certainty of the final results. The outcome of the CEA is the cost-effectiveness ratio (CER) or incremental cost-effectiveness ratio (ICER) that show amount of costs per effectiveness unit. Correct estimation of cost-effectiveness analysis makes it possible to increase health care economical resources distribution effectiveness and shows the most effective and respectable treatment instruments. This issue reviews all parts of cost-effectiveness analysis and algorithms of decision making during results estimation.

About this research paper

What this paper is about

Cost-effectiveness analysis (CEA) is a frequently used method of pharmacoeconomic analysis. Its major parts are cost analysis, effectiveness analysis and results estimation. Undertaking of each part effects the certainty of the final results. The outcome of the CEA is the cost-effectiveness ratio (CER) or incremental cost-effectiveness ratio (ICER) that show amount of costs per effectiveness unit. Correct estimation of cost-effectiveness analysis makes it possible to increase health care economical resources distribution effectiveness and shows the most effective and respectable treatment instruments. This issue reviews all parts of cost-effectiveness analysis and algorithms of decision making during results estimation.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cost-effectiveness analysis (CEA) is a frequently used method of pharmacoeconomic analysis. Its major parts are cost analysis, effectiveness analysis and results estimation. Undertaking of each part effects the certainty of the final results. The outcome of the CEA is the cost-effectiveness ratio (CER) or incremental cost-effectiveness ratio (ICER) that show amount of costs per effectiveness unit. Correct estimation of cost-effectiveness analysis makes it possible to increase health care economical resources distribution effectiveness and shows the most effective and respectable treatment instruments. This issue reviews all parts of cost-effectiveness analysis and algorithms of decision making during results estimation.

Key concepts: Incremental cost-effectiveness ratio, Cost-effectiveness analysis, Cost effectiveness, Estimation, Risk analysis (engineering), Cost estimate, Cost–benefit analysis, Computer science

Back to paper searchBrowse research topicsOriginal source
Методология анализа «Затраты -эффективность» при проведении фармакоэкономических исследований — Research Paper | ScholarLens